0

Assessment of Camel Heavy Chain Antibodies

Prepared Against Epidermal Growth Factor Receptor-2 and Human B-cell Membrane protein Lymphoma-2 for the Diagnosis of Human Tumors

Erschienen am 30.03.2019, 1. Auflage 2019
54,90 €
(inkl. MwSt.)

Nachfragen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9783659936531
Sprache: Englisch
Umfang: 112 S.
Format (T/L/B): 0.7 x 22 x 15 cm
Einband: kartoniertes Buch

Beschreibung

The absence of the light chains and CH1 domain in Camelidae heavy chain antibodies (HCAbs) give them many special characteristics that are different and superior to conventional antibody. HCAbs have the capability to resist heat and extreme pH without losing their activity. These advantages of HCAbs render them eligible to be used for diagnostic and therapeutic purposes. Mouse monoclonal antibodies and camel polyclonal antibodies against Her2, CD31 and Bcl2 peptides were produced, and assessed using ELISA, immunoblot and immunohistochemistry (IHC). In IHC, newly prepared C2B7 MCA anti-CD31-peptide was found be to as reactive as the commercially available anti-CD31 MCA. In contast, Anti-Her2 and anti-Bcl2 peptides MCA showed nonspecific staining reaction when they were tested on breast cancer and follicular hyperplasia tissues, respectively. Purified camel polyclonal anti-CD31-peptide antibodies staining specifically the blood vessel endothelial cells and nonspecifically epithelial cells. Purified camel polyclonal anti-Her2 peptide antibodies showed cytoplamsic reactivity.

Produktsicherheitsverordnung

Hersteller:
BoD - Books on Demand
info@bod.de
In de Tarpen 42
DE 22848 Norderstedt

Autorenportrait

Abdel-Rahman Mohammad Rawashdeh - B.Sc. in Biological Sciences, Yarmouk University, Irbid, Jordan, 2008.

Weitere Artikel vom Autor "Rawashdeh, Abdel Rahman"

Alle Artikel anzeigen